Matches in SemOpenAlex for { <https://semopenalex.org/work/W3203640930> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W3203640930 endingPage "2213" @default.
- W3203640930 startingPage "2208" @default.
- W3203640930 abstract "To measure and compare micro ribonucleic acid-16, survivin and tumour protein p53-regulated apoptosis-inducing protein 1 expression levels in preeclamptic and normotensive pregnancies, and to check the correlation of micro ribonucleic acid-16 with messenger ribonucleic acid expression of survivin and tumour protein p53.The observational cross-sectional comparative study was conducted at the Department of Physiology and Cell Biology, University of Health Sciences, Lahore, Pakistan, from 2016 to 2018, and comprised preeclamptic women in group A and normotensive women in group B. The preeclamptic patients were further categorised into early-onset preeclampsia subgroup A1and late-onset preeclampsia group A2. Expression of micro ribonucleic acid-16, messenger ribonucleic acid expression of survivin and tumour protein p53 in preeclamptic and normotensive pregnancies were analysed using real time polymerase chain reaction. Data was analysed using SPSS 22.Of the 54 patients, 27(50%) were in each of the two groups. Within group A, 14(52%) patients were in group A1 and 13(48%) in group A2. The expression of micro ribonucleic acid 16 showed significant increase in group A compared to group B (p<0.05). The difference was not significant between the subgroups A1 and A2. The levels of messenger ribonucleic acid expression of survivin and tumour protein p53 were deregulated in group A, with a decrease in survivin and an increase in tumour protein p53. The messenger ribonucleic acid expression of survivin and tumour protein p53 showed statistically significant differences across subgroups A1 and A2 (p<0.05). The micro ribonucleic acid-16 expression correlated negatively with messenger ribonucleic acid expression of survivin, but exhibited a positive correlation with tumour protein p53.Deregulated micro ribonucleic acid-16 along with differentially expressed apoptotic genes, survivin and tumour protein p53 might result in altered apoptosis implicated in the pathogenesis of preeclampsia." @default.
- W3203640930 created "2021-10-11" @default.
- W3203640930 creator A5053766900 @default.
- W3203640930 creator A5054135442 @default.
- W3203640930 creator A5055130737 @default.
- W3203640930 creator A5061508608 @default.
- W3203640930 creator A5061543025 @default.
- W3203640930 creator A5072663333 @default.
- W3203640930 date "2021-09-01" @default.
- W3203640930 modified "2023-10-11" @default.
- W3203640930 title "Expression levels of MiRNA-16, SURVIVIN and TP53 in Preeclamptic and Normotensive women." @default.
- W3203640930 doi "https://doi.org/10.47391/jpma.1171" @default.
- W3203640930 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34580516" @default.
- W3203640930 hasPublicationYear "2021" @default.
- W3203640930 type Work @default.
- W3203640930 sameAs 3203640930 @default.
- W3203640930 citedByCount "4" @default.
- W3203640930 countsByYear W32036409302021 @default.
- W3203640930 countsByYear W32036409302022 @default.
- W3203640930 crossrefType "journal-article" @default.
- W3203640930 hasAuthorship W3203640930A5053766900 @default.
- W3203640930 hasAuthorship W3203640930A5054135442 @default.
- W3203640930 hasAuthorship W3203640930A5055130737 @default.
- W3203640930 hasAuthorship W3203640930A5061508608 @default.
- W3203640930 hasAuthorship W3203640930A5061543025 @default.
- W3203640930 hasAuthorship W3203640930A5072663333 @default.
- W3203640930 hasConcept C104317684 @default.
- W3203640930 hasConcept C105580179 @default.
- W3203640930 hasConcept C121608353 @default.
- W3203640930 hasConcept C126322002 @default.
- W3203640930 hasConcept C134018914 @default.
- W3203640930 hasConcept C150194340 @default.
- W3203640930 hasConcept C16685009 @default.
- W3203640930 hasConcept C190283241 @default.
- W3203640930 hasConcept C2775975398 @default.
- W3203640930 hasConcept C2777218350 @default.
- W3203640930 hasConcept C2779234561 @default.
- W3203640930 hasConcept C54355233 @default.
- W3203640930 hasConcept C55493867 @default.
- W3203640930 hasConcept C71924100 @default.
- W3203640930 hasConcept C86803240 @default.
- W3203640930 hasConceptScore W3203640930C104317684 @default.
- W3203640930 hasConceptScore W3203640930C105580179 @default.
- W3203640930 hasConceptScore W3203640930C121608353 @default.
- W3203640930 hasConceptScore W3203640930C126322002 @default.
- W3203640930 hasConceptScore W3203640930C134018914 @default.
- W3203640930 hasConceptScore W3203640930C150194340 @default.
- W3203640930 hasConceptScore W3203640930C16685009 @default.
- W3203640930 hasConceptScore W3203640930C190283241 @default.
- W3203640930 hasConceptScore W3203640930C2775975398 @default.
- W3203640930 hasConceptScore W3203640930C2777218350 @default.
- W3203640930 hasConceptScore W3203640930C2779234561 @default.
- W3203640930 hasConceptScore W3203640930C54355233 @default.
- W3203640930 hasConceptScore W3203640930C55493867 @default.
- W3203640930 hasConceptScore W3203640930C71924100 @default.
- W3203640930 hasConceptScore W3203640930C86803240 @default.
- W3203640930 hasIssue "9" @default.
- W3203640930 hasLocation W32036409301 @default.
- W3203640930 hasOpenAccess W3203640930 @default.
- W3203640930 hasPrimaryLocation W32036409301 @default.
- W3203640930 hasRelatedWork W14311697 @default.
- W3203640930 hasRelatedWork W14443591 @default.
- W3203640930 hasRelatedWork W15063359 @default.
- W3203640930 hasRelatedWork W345235 @default.
- W3203640930 hasRelatedWork W5692599 @default.
- W3203640930 hasRelatedWork W6239716 @default.
- W3203640930 hasRelatedWork W6264972 @default.
- W3203640930 hasRelatedWork W6527102 @default.
- W3203640930 hasRelatedWork W938203 @default.
- W3203640930 hasRelatedWork W9602167 @default.
- W3203640930 hasVolume "71" @default.
- W3203640930 isParatext "false" @default.
- W3203640930 isRetracted "false" @default.
- W3203640930 magId "3203640930" @default.
- W3203640930 workType "article" @default.